Cachexia and head and neck squamous cell carcinoma: A scoping review

被引:2
|
作者
Porter, S. R. [1 ,2 ]
Ukwas, A. [1 ]
机构
[1] UCL Eastman Dent Inst, London, England
[2] UCL Eastman Dent Inst, UCL Rockefeller Bldg,21 Univ St, London WC1E 6DE, England
关键词
cachexia; head and neck neoplasms; squamous cell carcinoma of head and neck; CANCER CACHEXIA; SKELETAL-MUSCLE; WEIGHT-LOSS; DIAGNOSTIC-CRITERIA; NUTRITIONAL-STATUS; RADIOTHERAPY; PREVALENCE; MECHANISMS; IMPACT; UPDATE;
D O I
10.1111/odi.14749
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
ObjectiveThe objective of this paper was to provide an understanding of cachexia in relation to oral squamous cell carcinoma relevant to oral health care. The paper is a scoping review of aspects of the clinical presentation, aetiology and management of cachexia in relation to oral health and oral health care.MethodsA combined search of MEDLINE and EMBASE databases (via OVID) was conducted using the terms ([Head and Neck] OR [Oral Squamous Cell Carcinoma]) AND (Cachexia). Duplicates were removed and results were subsequently limited to studies published between 2000 and 2023, humans and English language. After screening and full-text assessment a total number of 87 studies were included in the review.ResultsIt is evident that cachexia is a not uncommon feature of patients with advanced malignancy of the head and neck driven by a multitude of mechanisms, induced by the tumour itself, that lead to reduced nutritional intake, increased metabolism and loss of adipose and skeletal tissue.ConclusionWhile a variety of nutritional, physical, psychological and pharmacological interventions may improve quality and duration of life, ultimately the diagnosis of cachexia in relation to head and neck cancer remains an indicator of poor life expectancy.
引用
收藏
页码:1746 / 1755
页数:10
相关论文
共 50 条
  • [31] Cetuximab A Review of its Use in Squamous Cell Carcinoma of the Head and Neck
    Frampton, James E.
    DRUGS, 2010, 70 (15) : 1987 - 2010
  • [32] The Evolving Transcriptome of Head and Neck Squamous Cell Carcinoma: A Systematic Review
    Yu, Yau-Hua
    Kuo, Hsu-Ko
    Chang, Kuo-Wei
    PLOS ONE, 2008, 3 (09):
  • [33] Gene polymorphisms and post-treatment toxicity and treatment response in head and neck squamous cell carcinoma: A scoping review
    Rajabi-Moghaddam, Mahdieh
    Abbaszadeh, Hamid
    ORAL SCIENCE INTERNATIONAL, 2023, 20 (03) : 151 - 164
  • [34] Biomarkers of squamous cell carcinoma of the head and neck
    Kim, J
    Shin, DM
    HISTOLOGY AND HISTOPATHOLOGY, 1997, 12 (01) : 205 - 218
  • [35] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Moskovitz, Jessica
    Moy, Jennifer
    Ferris, Robert L.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (02)
  • [37] Afatinib in squamous cell carcinoma of the head and neck
    Specenier, Pol
    Vermorken, Jan
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1295 - 1301
  • [38] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Hoesli R.C.
    Moyer J.S.
    Current Oral Health Reports, 2016, 3 (2) : 74 - 81
  • [39] Head and neck squamous cell carcinoma in childhood
    de Carvalho, MB
    Sobrinho, JD
    Rapoport, A
    Fava, AS
    Mendes, AF
    Kanda, JL
    Lehn, CN
    Chacra, J
    Menezes, MB
    Walder, F
    Franzi, SA
    MEDICAL AND PEDIATRIC ONCOLOGY, 1998, 31 (02): : 96 - 99
  • [40] Docetaxel and squamous cell carcinoma of the head and neck
    Calais, G
    BULLETIN DU CANCER, 2004, 91 (02) : 167 - 171